Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects

BACKGROUND: Pathogenic mutations in genes mediating homologous recombination (HR) DNA repair are present in 20-30% of men with metastatic castrate-resistant prostate cancer (mCRPC). Radium-223 is a bone-seeking α-emitter that induces double-strand DNA breaks, thereby killing cancer cells in the bone...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Urol
Autori principali: Velho, Pedro Isaacsson, Qazi, Fahad, Hassan, Sayeedul, Carducci, Michael A., Denmeade, Samuel R., Markowski, Mark C., Thorek, Daniel L., DeWeese, Theodore L., Song, Daniel Y., Tran, Phuoc T., Eisenberger, Mario A., Antonarakis, Emmanuel S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447475/
https://ncbi.nlm.nih.gov/pubmed/30293905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2018.09.040
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi